127 related articles for article (PubMed ID: 10390242)
1. In vitro activities of the everninomicin SCH 27899 and other newer antimicrobial agents against Borrelia burgdorferi.
Dever LL; Torigian CV; Barbour AG
Antimicrob Agents Chemother; 1999 Jul; 43(7):1773-5. PubMed ID: 10390242
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of faropenem, ertapenem, imipenem and meropenem against Borrelia burgdorferi s.l.
Rödel R; Freyer A; Bittner T; Schäfer V; Hunfeld KP
Int J Antimicrob Agents; 2007 Jul; 30(1):83-6. PubMed ID: 17512703
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of Borrelia and Leptospira to Quinupristin-dalfopristin (Synercid) in vitro.
Murgia R; Cinco M
New Microbiol; 2001 Apr; 24(2):193-6. PubMed ID: 11346304
[TBL] [Abstract][Full Text] [Related]
4. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies.
Dever LL; Jorgensen JH; Barbour AG
J Clin Microbiol; 1992 Oct; 30(10):2692-7. PubMed ID: 1400969
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of tigecycline against multiple strains of Borrelia burgdorferi.
Yang X; Nguyen A; Qiu D; Luft BJ
J Antimicrob Chemother; 2009 Apr; 63(4):709-12. PubMed ID: 19182236
[TBL] [Abstract][Full Text] [Related]
6. Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates.
Hunfeld KP; Kraiczy P; Wichelhaus TA; Schäfer V; Brade V
Int J Antimicrob Agents; 2000 Jun; 15(1):11-7. PubMed ID: 10856671
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi.
Hunfeld KP; Weigand J; Wichelhaus TA; Kekoukh E; Kraiczy P; Brade V
Int J Antimicrob Agents; 2001 Mar; 17(3):203-8. PubMed ID: 11282265
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto.
Sicklinger M; Wienecke R; Neubert U
J Clin Microbiol; 2003 Apr; 41(4):1791-3. PubMed ID: 12682190
[TBL] [Abstract][Full Text] [Related]
9. New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances.
Hunfeld KP; Kraiczy P; Wichelhaus TA; Schäfer V; Brade V
Eur J Clin Microbiol Infect Dis; 2000 Jan; 19(1):27-32. PubMed ID: 10706176
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi.
Kraiczy P; Weigand J; Wichelhaus TA; Heisig P; Backes H; Schäfer V; Acker G; Brade V; Hunfeld KP
Antimicrob Agents Chemother; 2001 Sep; 45(9):2486-94. PubMed ID: 11502519
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of an evernimicin (SCH27899) in vitro and in an animal model of Lyme disease.
Pavia CS; Wormser GP; Nowakowski J; Cacciapuoti A
Antimicrob Agents Chemother; 2001 Mar; 45(3):936-7. PubMed ID: 11181384
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.
Dever LL; Jorgensen JH; Barbour AG
Antimicrob Agents Chemother; 1993 May; 37(5):1115-21. PubMed ID: 8517700
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics.
Baradaran-Dilmaghani R; Stanek G
Infection; 1996; 24(1):60-3. PubMed ID: 8852472
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi.
Dever LL; Jorgensen JH; Barbour AG
Antimicrob Agents Chemother; 1993 Aug; 37(8):1704-6. PubMed ID: 8215288
[TBL] [Abstract][Full Text] [Related]
15. Eucaryotic cells protect Borrelia burgdorferi from the action of penicillin and ceftriaxone but not from the action of doxycycline and erythromycin.
Brouqui P; Badiaga S; Raoult D
Antimicrob Agents Chemother; 1996 Jun; 40(6):1552-4. PubMed ID: 8726038
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of linezolid, meropenem, and quinupristin-dalfopristin against group C and G streptococci, including vancomycin-tolerant isolates.
Zaoutis T; Moore LS; Furness K; Klein JD
Antimicrob Agents Chemother; 2001 Jul; 45(7):1952-4. PubMed ID: 11408207
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of Borrelia burgdorferi strains isolated in the Czech Republic.
Janovská D; Hulínská D; Godová T
Cent Eur J Public Health; 2001 Feb; 9(1):38-40. PubMed ID: 11243589
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents.
Levin JM; Nelson JA; Segreti J; Harrison B; Benson CA; Strle F
Antimicrob Agents Chemother; 1993 Jul; 37(7):1444-6. PubMed ID: 8363373
[TBL] [Abstract][Full Text] [Related]
19. In-vitro susceptibility of Borrelia burgdorferi and Borrelia hermsii to ten antimicrobial agents.
Sambri V; Massaria F; Cevenini R; La Placa M
J Chemother; 1990 Dec; 2(6):348-50. PubMed ID: 2093104
[TBL] [Abstract][Full Text] [Related]
20.
Koetsveld J; Manger A; Hoornstra D; Draga RO; Oei A; Kolyasnikova NM; Toporkova MG; Sarksyan DS; Wagemakers A; Platonov AE; Hovius JW
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
